Results 131 to 140 of about 232,732 (288)

and Development, from the Individual Researcher to research Empires [PDF]

open access: yes, 2012
This paper is dated: it was written at the time of the celebration of the 20 years of activity of the Évora Geophysics Centre (CGE). It comprises a brief appraisal of the evolution of scientific research in Europe and in the United States of America ...
Reis, A. Heitor
core  

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun   +4 more
wiley   +1 more source

Understanding the influence of transfusion and blood loss on tranexamic acid concentration in scoliosis surgery with blood loss

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Tranexamic acid (TXA) stabilizes clot formation by inhibiting fibrin degradation and improves postoperative outcomes. However, rare adverse events (e.g., thrombosis, seizures) warrant dose–risk evaluation. This study examines how perioperative blood loss and transfusion practices affect TXA concentrations during paediatric scoliosis surgery ...
Paula Alexandra Sá   +4 more
wiley   +1 more source

Prescribing variation across Europe: Insights into prescribing practices and educational needs

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Prescribing medication is a complex process, influenced by many factors that can be weighed differently. Four prescriber profiles have been identified: pragmatic‐contextual, guideline‐oriented, experience‐driven and vulnerability‐focused. However, the extent to which European prescribers identify with these profiles and the role of these profiles ...
Mariëlle G. Hartjes   +3 more
wiley   +1 more source

Portuguese Voyages to America in the Fifteenth Century. [PDF]

open access: yesThe Hispanic American Historical Review, 1941
William B. Greenlee   +1 more
  +4 more sources

Linguistic contact in the 18th Century in America: Spanish and Portuguese in Paraguay

open access: yesCuadernos Dieciochistas, 2013
Although Spanish and Portuguese coexist in several areas of America, almost all studies have focused on the contact situation in the North of Uruguay, and this contact has been hardly considered from a historical point of view.
José Luis RAMÍREZ LUENGO
doaj  

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Luso-American Literature: Writings by Portuguese-Speaking Authors in North America

open access: yesCadernos de Letras da UFF, 2017
Reviewed book:MOSER, R.; TOSTA, A. (Eds.). Luso-American Literature: Writings by Portuguese-Speak­ing Authors in North America. New Brunswick, NJ: Rutgers University Press, 2011. 375 p.
Orison Marden Bandeira de Melo Jr.
doaj  

Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta‐analysis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy